Pregnancy and Developmental Outcomes After Transfer of Reportedly Aneuploid or Mosaic Embryos

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-55
SponsorStanford University

About this trial

To determine how often embryos reported to be abnormal by preimplantation genetic testing result in liveborn infants. To evaluate whether the pregnancies that result from these embryos are higher risk for complications and whether the resulting babies have higher risk for health or developmental issues in the first five years after birth.

Eligibility criteria

Qualifiers

Available aneuploid or mosaic embryos

No other acceptable embryos available

Willing to travel to Stanford for treatment

English language fluency

Disqualifiers

Use of international donor eggs or sperm not tested according to FDA guidelines.

Living outside the United States

Embryos with Triploidy are not eligible for transfer in this protocol

Trial design

Treatments tested in this trial

  • Non-euploid embryo transfer
  • Euploid Transfer

Treatment groups

300 Participants
are divided into 2 treatment groups

Sponsors and collaborators